Clinical Trials
18 trialsNCT03049462 2026-05-22
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT07095517 2026-02-27
PROSPECT
Massachusetts General Hospital
Phase 1 Recruiting
NCT05542407 2026-01-29
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
NCT05443425 2025-07-04
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
City of Hope Medical Center
Phase 1 Recruiting
NCT06860789 2025-03-06
AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Akeso
Phase 1 Not yet recruiting
NCT04116203 2025-02-28
PCOS
University of Alberta
Phase 1 Completed
NCT06642363 2024-10-17
The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome
Isfahan University of Medical Sciences
Phase 1 Recruiting
NCT05251727 2024-08-19
Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients
Veloxis Pharmaceuticals
Phase 1 Terminated
NCT04205071 2021-01-19
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 1 Withdrawn
NCT01092975 2020-12-28
Safety of Phenylephrine for Oral Mucositis Prevention
University of Wisconsin, Madison
Phase 1 Terminated
NCT01300611 2020-12-08
USBTXA127CBT
Tarix Pharmaceuticals
Phase 1 Terminated
NCT02094950 2019-07-23
Acupuncture Feasibility Trial for Dyspnea in Lung Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00933309 2016-02-19
The Impact of Obesity and Obesity Treatments on Breast Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00070616 2014-10-24
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support
Swedish Orphan Biovitrum
Phase 1 Completed
NCT00482846 2014-04-15
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT01728480 2013-12-11
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT00427102 2012-11-14
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT00584597 2010-12-13
TRAUMEEL
University of Oklahoma
Phase 1 Completed